• 1. A high throughput immunoassay for the therapeutic drug monitoring of tegafur
  Marta Broto,Rita McCabe,Roger Galve,M.-Pilar Marco Analyst 2017 142 2404
• 2. Room-temperature reactions of CsSO4F with organic molecules containing heteroatoms
  Stojan Stavber,Marko Zupan J. Chem. Soc. Chem. Commun. 1983 563
• 3. Room-temperature reactions of CsSO4F with organic molecules containing heteroatoms
  Stojan Stavber,Marko Zupan J. Chem. Soc. Chem. Commun. 1983 563
• 4. 11??Organic photochemistry
  Mary K. Boyd,Garrett M. Zopp Annu. Rep. Prog. Chem. Sect. B: Org. Chem. 2003 99 396

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Professional Introduction to 2,4(1H,3H)-Pyrimidinedione,5-fluoro-1,3-dimethyl- (CAS No. 3013-92-1)

2,4(1H,3H)-Pyrimidinedione,5-fluoro-1,3-dimethyl-, identified by the Chemical Abstracts Service Number (CAS No.) 3013-92-1, is a significant compound in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic compound belongs to the pyrimidine derivatives, a class of molecules widely recognized for their biological activity and pharmacological potential. The structural features of this compound, particularly the presence of a fluoro substituent and dimethyl groups, contribute to its unique chemical properties and make it a subject of considerable interest in drug discovery and development.

The fluoro group at the 5-position of the pyrimidine ring is a key structural determinant that influences the electronic and steric properties of the molecule. Fluorine atoms are known to enhance metabolic stability, improve binding affinity to biological targets, and modulate pharmacokinetic profiles. In the context of 2,4(1H,3H)-Pyrimidinedione,5-fluoro-1,3-dimethyl-, the fluorine atom may play a crucial role in its interaction with enzymes and receptors, potentially leading to enhanced efficacy or selectivity in therapeutic applications.

The dimethyl groups at the 1 and 3 positions further contribute to the molecular complexity and influence its reactivity. These alkyl groups can affect the compound's solubility, lipophilicity, and overall bioavailability. The combination of these substituents in 2,4(1H,3H)-Pyrimidinedione,5-fluoro-1,3-dimethyl- suggests a potential for diverse biological activities. Pyrimidine derivatives are well-documented for their roles in various biological processes, including DNA synthesis and repair.

Recent research has highlighted the importance of pyrimidine-based compounds in medicinal chemistry. Studies have demonstrated that modifications at specific positions within the pyrimidine ring can lead to significant changes in biological activity. For instance, compounds with fluorine substitutions have been shown to exhibit improved pharmacological properties compared to their non-fluorinated counterparts. The presence of fluoro and dimethyl groups in 2,4(1H,3H)-Pyrimidinedione,5-fluoro-1,3-dimethyl- aligns it with this trend.

In clinical research settings, 2,4(1H,3H)-Pyrimidinedione, particularly derivatives with fluorine and dimethyl substitutions, have been explored for their potential therapeutic applications. These compounds have shown promise in preclinical studies as inhibitors or modulators of various enzymes and pathways involved in diseases such as cancer and inflammatory disorders. The structural features of this compound make it a valuable scaffold for further derivatization and optimization.

The synthesis of 2,4(1H,3H)-Pyrimidinedione, including its fluorinated and dimethylated analogs, involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been developed to enhance yield and purity while minimizing side reactions. Techniques such as fluorination reactions using palladium-catalyzed cross-coupling or nucleophilic aromatic substitution are commonly employed.

The pharmacokinetic profile of 2,4(1H,3H)-Pyrimidinedione, particularly its absorption distribution metabolism and excretion (ADME) properties, is another critical aspect that researchers focus on. The presence of fluoro and dimethyl groups can influence these properties significantly. For example, fluorine substitution can increase metabolic stability by resisting hydrolysis under physiological conditions, whereas dimethyl groups can enhance lipophilicity.

Computational modeling and molecular dynamics simulations have become indispensable tools in studying the interactions between 2,4(1H,3H)-Pyrimidinedione, its analogs, and biological targets. These computational approaches allow researchers to predict binding affinities, identify potential drug candidates, and optimize molecular structures for improved therapeutic efficacy.

The future prospects for 2,4(1H,3H)-Pyrimidinedione, especially derivatives with fluoro and dimethyl substitutions, are promising. Ongoing research aims to explore novel synthetic routes, develop new derivatives, and evaluate their biological activity in vitro and in vivo. Collaborative efforts between academia and industry are essential to translate these findings into clinical applications that benefit patients worldwide.

• 137442-18-3( )
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)